“With the CX series of machines, we have further enhanced reliability and continue to consistently produce high-quality components for the medical and healtcare industry worldwide”, emphasizes Roger Samuelsson, CEO SHL Group. The company is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, such as auto injectors, pen injectors and inhalers. When manufacturing these systems the quality of all components must be absolutely identical. Thus, verifiable compliance with the most stringent quality standards must be guaranteed when running production 24/7. “Our goal is zero error tolerance, a goal that our partners must share with us. KraussMaffei is a preferred while excellent partner for us”, Samuelsson stated. Now more than 130 KraussMaffei CX machines are producing medical devices at several SHL plants in Taiwan. The machines allow SHL Group to produce according to Good Manufacturing Practice (GMP) guidelines, distinguished by high process reliability and exact repeatability of the single components during synchronized assembly methods. “We appreciate the new order of SHL Group very much”, said Michael Müller, Vice President Injection Molding Sales of KraussMaffei Group affiliate in China. “Our goal is to achieve the highest possible customer satisfaction and an example of our success in achieving such a goal is our longstanding partnership with SHL Group”.